XML 22 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Adoption of new accounting standard
Common Stock
Additional paid-in capital
Warrants
Retained earnings (Accumulated deficit)
Retained earnings (Accumulated deficit)
Adoption of new accounting standard
Accumulated other comprehensive income (loss)
Beginning Balance, (in shares) at Dec. 31, 2017     27,572          
Beginning Balance at Dec. 31, 2017 $ 485,329 $ 16 $ 275 $ 292,494 $ 0 $ 210,265 $ 16 $ (17,705)
Net loss (262,987)         (262,987)    
Dividends declared or accrued for common stock (8,803)     (2,968)   (5,835)    
Shares issued (in shares)     14,375          
Shares issued 217,312   $ 144 217,168        
Shares issued for option exercises (in shares)     27          
Shares issued for option exercises 274     274        
Share-based compensation expense (in shares)     165          
Share-based compensation expense 4,384   $ 2 4,382        
Restricted shares and performance shares forgiven for taxes and forfeited (in shares)     (35)          
Restricted shares and performance shares forgiven for taxes and forfeited (805)     (805)        
Change in estimate of share-based award vesting (1,840)     (1,890)   50    
Change in fair value, net of tax 0              
Reclassification adjustment for losses included in net loss, net of tax 0              
Foreign currency translation loss (13,609)             (13,609)
Ending Balance at Dec. 31, 2018 419,271 $ (51) $ 421 508,655 0 (58,491) $ (51) (31,314)
Ending Balance, (in shares) at Dec. 31, 2018     42,104          
Net loss (46,741)         (46,741)    
Dividends declared or accrued for common stock (8,933)     (8,933)        
Dividends accrued for preferred stock (642)     (642)        
Shares issued for option exercises (in shares)     5          
Shares issued for option exercises 21     21        
Share-based compensation expense (in shares)     248          
Share-based compensation expense 3,933   $ 2 3,931        
Restricted shares and performance shares forgiven for taxes and forfeited (in shares)     (44)          
Restricted shares and performance shares forgiven for taxes and forfeited (365)     (365)        
Change in estimate of share-based award vesting (1,052)     (1,052)        
Change in fair value, net of tax (10,479)             (10,479)
Reclassification adjustment for losses included in net loss, net of tax 1,084             1,084
Foreign currency translation loss (3,845)             (3,845)
Ending Balance at Dec. 31, 2019 353,277   $ 423 501,615 1,076 (105,283)   (44,554)
Ending Balance, (in shares) at Dec. 31, 2019     42,313          
Warrants 1,076       1,076      
Net loss (100,592)         (100,592)    
Dividends accrued for preferred stock (12,373)     (12,373)        
Share-based compensation expense (in shares)     417          
Share-based compensation expense 4,969   $ 4 4,965        
Restricted shares and performance shares forgiven for taxes and forfeited (in shares)     (44)          
Restricted shares and performance shares forgiven for taxes and forfeited (157)     (157)        
Change in estimate of share-based award vesting (718)     (718)        
Reclassification of warrants to liabilities (Note 21) (1,076)       (1,076)      
Change in fair value, net of tax (12,443)             (12,443)
Reclassification adjustment for losses included in net loss, net of tax 18,987             18,987
Foreign currency translation loss (1,683)             (1,683)
Sale of discontinued operations 5,961             5,961
Ending Balance at Dec. 31, 2020 254,152   $ 427 $ 493,332 $ 0 $ (205,875)   $ (33,732)
Ending Balance, (in shares) at Dec. 31, 2020     42,686          
Warrants $ 0